09
Aug
Editors note: Next up we will look at the investors that have increased their pace at this stage in the first half of 2024. Although Series A and B funding for U.S.-based companies picked up in H1 2024 — up 34% year over year — the uptick may be deceiving. While total funding reached $31.5 billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. That includes a $6 billion Series B to xAI, which accounts for much of the increase.…